April 07, 2020
- Solaris Admin
- Apr 6, 2020
- 1 min read
Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration on for its Abbreviated New Drug Application for Acyclovir Ointment USP, 5% in 15 g and 30 g tubes, a generic version of reference listed drug ZOVIRAX (acyclovir) Ointment 5%. For more updates, please feel free to email us info@solaris-pharma.com
Comentarios